Battles between the Trump administration and academic institutions are putting important biomedical advances in limbo.

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

OncoVanguard8 is a leading service provider for innovative healthcare products for insurance companies operating in Peru, Colombia and Ecuador ...

By understanding how gestational diabetes disrupts the placenta at the molecular level, we can begin to imagine new ways to ...

Two pioneering studies by researchers from the School of Zoology and the Steinhardt Museum of Natural History at Tel Aviv ...

The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...

Baylor College of Medicine’s Center for Precision Medicine Models has received a five-year, $10 million grant from the ...

Dr. Comfort is a historian of genetics who is completing a biography of James Watson. At first, James Watson terrified me. It ...

Genetics research and cognitive theory together are revealing autism’s biological depth and cognitive richness, shaping a ...

Schizophrenia, a psychiatric disorder that affects how a person feels, thinks, and behaves, affects roughly 1% of the ...

Semax, a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), derived from adrenocorticotropic hormone (ACTH), has emerged as a subject of growing interest in various scientific domains, ...